NGS IVF in Bangkok allows full genetic screening of IVF embryos. It uses high-throughput sequencing to analyse the embryo’s entire genome, distinguishing chromosomally normal (euploid) embryos from those with abnormalities that cause implantation failure or miscarriage. It achieves 97–99% accuracy for full chromosomal issues, making it the current gold standard for preimplantation genetic testing. This technology drastically improves IVF success rates rather than being an optional extra. For couples with repeated IVF failures or miscarriages, clinics now offer highly precise testing of all 23 chromosome pairs — a breakthrough impossible a decade ago.
According to a 2025 peer-reviewed study published in Frontiers in Endocrinology, which analyzed 818 IVF cycles from 797 patients with recurrent pregnancy loss, the use of PGT-A with NGS technology significantly improves outcomes. For patients under 38 years old, the clinical pregnancy rate reached 63.64% with PGT-A, compared to 55.03% without it. For those who had experienced three or more miscarriages, the clinical pregnancy rate jumped from 42.13% to an impressive 74.70%. These numbers offer genuine hope for couples who have endured repeated pregnancy loss or multiple failed IVF cycles.
The Frontiers in Endocrinology study documented that PGT-A using NGS technology consistently outperforms conventional IVF across several key patient subgroups:
|
Patient Group |
Indicator |
Without PGT-A |
With PGT-A |
Improvement |
|
Patients under 38 |
Clinical pregnancy rate |
55.03% |
63.64% |
Significant increase |
|
Live birth rate |
43.25% |
53.03% |
Significant increase |
|
|
Patients with 3 previous miscarriages |
Clinical pregnancy rate |
42.13% |
74.70% |
Dramatic increase |
|
Live birth rate |
32.02% |
55.42% |
More than doubled |
|
|
Patients with 2 previous miscarriages |
Clinical pregnancy to live birth conversion |
/ |
/ |
Significantly improved |
In essence, these numbers tell a story of prevention rather than reaction. Conventional IVF transfers embryos and hopes for the best. NGS-based PGT-A screens embryos first and transfers only those with the highest potential for success.
The technology achieves this through three fundamental advantages:
1. NGS offers unmatched detection accuracy.
2. NGS enables more effective embryo selection.
3. NGS reduces the time to pregnancy.
Yes — and the evidence from the Frontiers study is strongest for specific groups. For patients under 38 with normal ovarian reserve, PGT-A improved live birth rates from 40.56% to 49.41%. For those with three previous miscarriages, the live birth rate more than doubled — from 32.02% to 55.42%.
That said, not everyone benefits equally. For patients aged 38 or older, PGT-A raised clinical pregnancy rates (50.63% vs. 35.42%), but the increase in live birth rate did not reach statistical significance. This does not mean older patients gain nothing — rather, the benefit may be smaller, and factors like ovarian reserve matter more. For those with diminished ovarian reserve, a cautious, individualized approach is essential.
The answer depends on the type of genetic screening being performed.
For standard aneuploidy screening (PGT-A) using NGS, results typically take between 5 and 7 days after the embryo biopsy.
Some laboratories can produce preliminary results within 24 hours, but complete reports require additional time for data analysis and rechecking. If the clinic offers expedited services, turnaround time can sometimes be shortened to 3 to 7 days.
For more complex genetic testing, the timeline extends. Single-gene disorder screening (PGT-M) generally requires approximately 14 days for results, as it involves identifying specific inherited conditions.
Structural rearrangement screening (PGT-SR) — used for couples with chromosomal translocations or inversions — can take up to a month, given the complexity of the analysis.
Several factors affect how quickly you receive your NGS results. These include:
1. Number of embryos tested: More embryos generate more genetic data, which can extend processing time by a day or two.
2. Laboratory equipment and technology: Modern, high‑throughput NGS platforms deliver faster and more reliable results than older systems.
3. Embryology team experience: Skilled teams perform biopsies efficiently and handle samples with fewer errors, avoiding unnecessary delays.
4. Need for retesting: Inconclusive results or technical issues may require retesting, adding several days or even weeks to the timeline.
Fortunately, most routine PGT‑A cycles fall within the standard 5‑to‑7‑day window, and delays are uncommon in accredited labs.
NGS IVF Bangkok clinic accreditation standards are rigorous, but not every clinic meets them. Here is what an accredited clinic looks like:
The first area to examine is laboratory credentials. An accredited clinic should hold ISO 15189 accreditation — the international standard for medical laboratory quality and competence.
Some of Bangkok’s leading clinics also hold CAP (College of American Pathologists) certification and RTAC (Reproductive Technology Accreditation Committee) accreditation from Australia and New Zealand.
RTAC is widely regarded as the gold standard in fertility laboratory quality, evaluating every component of a fertility clinic — from infrastructure and medical teams to laboratory operations and treatment protocols.
The second area to examine is the embryology team. An accredited clinic employs embryologists who hold certification from ESHRE (European Society of Human Reproduction and Embryology) or equivalent recognized bodies.
An experienced embryology team is essential for performing trophectoderm biopsies correctly and for maintaining high blastocyst survival rates through vitrification.
The third area to examine is the equipment. Accredited clinics use time-lapse imaging systems (such as EmbryoScope) and high-throughput NGS platforms (such as Illumina systems). Time-lapse technology allows for continuous monitoring of embryo development without removing embryos from their controlled environment.
The fourth area to examine is transparency. An accredited clinic will openly share its success rates, accreditation status, and laboratory protocols. Additionally, the clinic should be providing age-stratified data rather than vague overall percentages.
As an accredited clinic, it should be willing to answer detailed questions about its laboratory protocols, biopsy techniques, and vitrification methods.
From a business research perspective, cost is a critical factor for most international patients. According to the Thailand Health Administration (THA), the average medical expenditure for international patients undergoing IVF in Thailand ranges from approximately $7,000 to $13,000 USD (350,000 to 650,000 Thai Baht).
For an NGS-based PGT-A cycle (third-generation IVF), patients should generally budget between $9,000 and $15,000 USD (approximately 450,000 to 750,000 Thai Baht) for medical fees alone, depending on the clinic, the number of embryos screened, and the complexity of the genetic testing required.
When comparing Bangkok to Western destinations, the savings are substantial. According to 2025 pricing data from medical tourism platforms and fertility clinics, a standard IVF cycle in Bangkok ranges from $7,000 to $9,000 USD, compared to $15,000 to $25,000 USD in the United States — a saving of roughly 60 percent.
For an ICSI cycle with PGT-A, Bangkok prices range from $9,000 to $12,000 USD, compared to $22,000 to $35,000 USD in the United States — a saving of roughly 65 percent. Australia's IVF costs similarly fall within $15,000–$25,000 USD for standard cycles, though out-of-pocket expenses can be lower depending on insurance coverage.
|
IVF Type |
Thailand (Bangkok) |
United States |
Estimated Savings |
|
Standard IVF Cycle |
$7,000 – $9,000 |
$15,000 – $25,000 |
~60% |
|
IVF + PGT-A (per cycle) |
$9,000 – $12,000 |
$22,000 – $35,000 |
~65% |
These savings do not come at the expense of quality. As noted earlier, Bangkok’s leading accredited clinics maintain international certification standards comparable to those in Western countries. The price difference primarily reflects lower operational costs and favorable exchange rates, not compromised medical outcomes.
When comparing high success rate IVF Bangkok clinics to those in neighboring countries, the trade-offs become clearer.
|
Destination |
PGT-A Cycle Cost (USD) |
Technology & Accreditation |
Medica Tourism Support |
|
Thailand (Bangkok) |
$9,000 – $12,000 |
ISO 15189, RTAC, CAP; ESHRE-certified embryologists |
Extensive (English coordinators, visa, transfers, accommodation) |
|
Singapore |
Often > $18,000 |
High standard, but at a steep premium |
Good, but living costs much higher |
|
Malaysia |
Slightly lower than Bangkok |
Fewer NGS clinics; lower patient volume → less experienced teams |
Developing |
|
Vietnam |
$6,000 – $8,000 (emerging) |
Technology & accreditation are still maturing; less established regulation |
Limited |
Western-standard NGS technology and international accreditations at roughly half the price of the US or Australia, supported by a mature medical tourism infrastructure. For couples paying entirely out of pocket, Bangkok remains one of the most cost-effective choices for NGS-based IVF without compromising clinical outcomes.
Read More: IVF Thailand: Your Practical Guide to Choosing the Best IVF Clinic and Plan
Choosing to pursue NGS IVF Bangkok is a decision to embrace the best that modern reproductive medicine has to offer. NGS-based PGT-A significantly improves both clinical pregnancy rates and live birth rates, offering genuine hope to families who have waited far too long.